Tags » GlaxoSmithKline

GlaxoSmithKline Gets Approval Recommendation for Gene Therapy

Recently, Strimvelis received a positive regulatory opinion from EMA’s Committee for Medicinal Products for Human Use (CHMP). Strimvelis is a gene therapy treatment developed by… 191 more words

Committee For Medicinal Products For Human Use

Seroxat Study 329 Opens The Pandora’s Box For All Bogus Anti-Depressant Studies…. — GSK : Licence To (K) ill (Documenting GSK And Seroxat)

http://www.madinamerica.com/2016/05/researchers-deconstruct-ghostwritten-industry-trial-for-antidepressant/ Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant In The News May 14, 2016 Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy […]

22 more words

Folkhälsomyndigheten köper ny narkolepsiskandal från grovt kriminellt företag!

ANALYS. Trots att hundratals personer fick narkolepsi, dvs hjärnskador efter massvaccinationerna mot svininfluensan 2009, har Folkhälsomyndigheten tecknat ett avtal för exakt samma pandemivaccin. Detta trots kännedom om vaccinets risker. 43 more words

Dividende von GlaxoSmithKline

Gestern erfolgte die Gutschrift der Halbjahresdividende vom britischen Pharmaunternehmen GlaxoSmithKline PLC in Höhe von 29,93 EUR. Insgesamt erhielten wir vom Unternehmen bisher 52,90 EUR an Ausschüttungen oder 3,49% auf unser eingesetztes Kapital. 37 more words


Calls for pharma to follow GSK and make drugs more accessible

Poor countries will soon be able to make their own versions of GlaxoSmithKline’s drugs without paying royalties, the UK-based pharma giant has announced.

Building on… 209 more words

GlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy

An European regulatory panel has recommended approval for GlaxoSmithKline’s Strimvelis, a gene therapy for the treatment of Bubble Boy disease. It would be the first children’s gene therapy approved in Europe if it receives final marketing clearance from the European Commission. 238 more words